Salem Investment Counselors Inc. Lowers Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Salem Investment Counselors Inc. lessened its position in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 2.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,503 shares of the company’s stock after selling 840 shares during the quarter. Salem Investment Counselors Inc.’s holdings in Henry Schein were worth $2,180,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of HSIC. City State Bank acquired a new position in shares of Henry Schein in the fourth quarter worth $55,000. Czech National Bank grew its stake in Henry Schein by 4.7% during the 4th quarter. Czech National Bank now owns 27,034 shares of the company’s stock worth $1,871,000 after purchasing an additional 1,223 shares in the last quarter. Pensionfund Sabic increased its holdings in Henry Schein by 34.5% during the 4th quarter. Pensionfund Sabic now owns 19,500 shares of the company’s stock worth $1,349,000 after purchasing an additional 5,000 shares during the period. Nordea Investment Management AB raised its position in Henry Schein by 8.6% in the 4th quarter. Nordea Investment Management AB now owns 10,974 shares of the company’s stock valued at $761,000 after purchasing an additional 869 shares in the last quarter. Finally, Central Pacific Bank Trust Division boosted its stake in shares of Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after buying an additional 200 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Up 1.5 %

NASDAQ:HSIC opened at $70.70 on Tuesday. The company has a market capitalization of $8.81 billion, a PE ratio of 29.09, a P/E/G ratio of 2.30 and a beta of 0.89. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The stock’s 50 day moving average price is $72.14 and its 200 day moving average price is $70.47. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Analyst Ratings Changes

HSIC has been the topic of a number of recent research reports. Barrington Research restated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $79.40.

Get Our Latest Stock Analysis on Henry Schein

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.14% of the company’s stock.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.